⌘K
t
AstraZeneca PLC issued an RNS announcement on 05 November 2024. The company stated its policy not to comment on speculative media reports, including those related to ongoing investigations in China. AstraZeneca also confirmed it would fully cooperate with Chinese authorities if requested and that its operations in China are ongoing.
| Date | 5 Nov 2024 |
| Time | 16:49:43 |
| Category | Corporate updates |
| ID | 0561L |
05 November 2024
AZN share price movement
As a matter of policy, we do not comment on speculative media reports including those related to ongoing investigations in China.
If requested, we will fully cooperate with the Chinese authorities.
We continue to deliver our life changing medicines to patients in China and our operations are ongoing.
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on social media @AstraZeneca
Adrian Kemp
Company Secretary
AstraZeneca PLC